Daewoong Pharm expands Nabota Master Class to train global doctors, strengthen K-beauty leadership

Daewoong Pharmaceutical announced Tuesday that it will expand its Nabota Master Class (NMC) to four annual sessions, strengthening Nabota’s global presence through professional medical education.

Under the new format, Daewoong Pharm will invite medical professionals from Asia, Latin America, and the Middle East to Seoul and provide tailored academic programs for each region.

The first of the expanded sessions -- the Asia-Pacific (APAC) training program -- was held last Wednesday. Additional sessions for medical professionals from Argentina and the Middle East are scheduled for later this year.

Foreign medical professionals toured Daewoong Pharmaceutical's Nabota Hyangnam Plant in Hwaseong, Gyeonggi Province, last Wednesday. (Courtesy of Daewoong Pharmaceutical)

Nabota has been rapidly expanding its global footprint this year, securing major export contracts worth 73.8 billion won ($51.2 million) in Thailand and 180 billion won ($125 million) in Brazil, the largest in Asia and Latin America, respectively. The botulinum toxin brand also debuted in key Middle Eastern markets, including Saudi Arabia and Qatar.

Daewoong Pharmaceutical said it is transforming the NMC into a comprehensive educational platform to enhance Nabota’s value, foster trust among medical professionals, and promote Korean aesthetics worldwide.

The Deep Nabota Master Class APAC, held in Seoul, exemplified this new direction. More than 40 medical professionals from five countries participated in region-specific, hands-on training that emphasized patient-tailored treatment and multidisciplinary approaches.

The event featured lectures, live demonstrations, factory tours, and visits to leading K-Beauty medical sites. The program highlighted trends in non-invasive, combination, and personalized aesthetic procedures that reflect the evolving concept of natural beauty.

Key speakers included Dr. Yoon Chun-sik (Yemiwon Dermatology Clinic), Dr. Park Je-young (Apgujeong Oracle Clinic), Professor Han Seung-ho (Ewha Womans University), Dr. Park Young-woon (Villard Skin Dermatology Clinic), Dr. Bae Kyung-tae (It’s Me Sejong Clinic), Dr. Ko Beom-joon (Doctor’s Dermatology Clinic Sinsa), Dr. Kook Ji-soo (It’s Me Ansan Clinic), and Dr. Kim Sun-wook (Avijoo Clinic Gangseo).

These experts shared advanced K-Beauty insights, including Nabolift and Naboglow, Nabota’s signature treatment techniques, and combination procedures using V-olet and Nabota, which drew enthusiastic responses from participants.

Customized regional sessions were also held. A “Case Sharing and Discussion” program allowed APAC physicians, including those from Thailand and Indonesia, to present localized treatment methods and clinical case studies, fostering active cross-border exchange.

“It was meaningful to share and discuss the latest clinical cases with global peers. The program -- from Nabota technique training to visiting Korean clinics -- offered valuable new perspectives and growth opportunities,” said Dr. Sirinya Prabriputaloong from Thailand.

Yoon Jun-soo, Head of the Nabota Business Division at Daewoong Pharmaceutical, commented, “We will continue to accelerate our global market expansion by making Daewoong Pharmaceutical’s patient-centered treatment philosophy our core strategy.”

He added that the company plans to further develop the Nabota Master Class into a global academic exchange platform where medical professionals can grow and innovate together, beyond simple procedural training.